7 Iowa opinions name it 2 courts 1994–2019 0 in the last five years
The cases below were cited by Iowa courts in a sentence that names this issue. Sides come from how each citing opinion treated the case (Syfertize flag on that citation), so a case can appear on both: that is where the law is contested. A red or yellow chip is the case's own overall treatment.
| Case | Followed | Cited |
|---|---|---|
Hillrichs v. Avco Corp.green1 sentence2019See id. at 98 (“Proof that the defendant comported with the state of the art of the time of manufacture is a defense to a design defect claim . . . .”). | 1 | 1 |
Conte v. Wyeth, Inc.green2 sentences2014Therefore, the Court finds that the plaintiffs have adequately stated a design defect claim against Lilly.”); Wyeth, Inc. v. Weeks, ___ So.3d ___, ___, 2013 WL 135753 , at 19 (Ala. Jan. 11, 2013), reargument granted (June 13, 2013) (“Under Alabama law, a brand-name drug company may be held liable for fraud or misrepresentation (by misstatement or omission), based on statements it made in connection with the manufacture of a brand-name prescription drug, by a plaintiff claiming physical injury caused by a generic drug manufactured by a different company.”); Conte v. Wyeth, Inc., 85 Cal. Rptr. 3 2014Therefore, the Court finds that the plaintiffs have adequately stated a design defect claim against Lilly.”); Wyeth, Inc. v. Weeks, — So.3d-,-, 2013 WL 135753 , at *19 (Ala. Jan. 11, 2013), reargument granted (June 13, 2013) (“Under Alabama law, a brand-name drug company may be held liable for fraud or misrepresentation (by misstatement or omission), based on statements it made in connection with the manufacture of a brand-name prescription drug, by a plaintiff claiming physical injury caused by a generic drug manufactured by a different company.”); Conte v. Wyeth, Inc., 168 Cal.App.4th 89 , 8 | 1 | 1 |
Lance v. Wyethgreen2 sentences2014Therefore, the Court finds that the plaintiffs have adequately stated a design defect claim against Lilly.”); Wyeth, Inc. v. Weeks, ___ So.3d ___, ___, 2013 WL 135753 , at 19 (Ala. Jan. 11, 2013), reargument granted (June 13, 2013) (“Under Alabama law, a brand-name drug company may be held liable for fraud or misrepresentation (by misstatement or omission), based on statements it made in connection with the manufacture of a brand-name prescription drug, by a plaintiff claiming physical injury caused by a generic drug manufactured by a different company.”); Conte v. Wyeth, Inc., 85 Cal. Rptr. 3 2014Therefore, the Court finds that the plaintiffs have adequately stated a design defect claim against Lilly.”); Wyeth, Inc. v. Weeks, — So.3d-,-, 2013 WL 135753 , at *19 (Ala. Jan. 11, 2013), reargument granted (June 13, 2013) (“Under Alabama law, a brand-name drug company may be held liable for fraud or misrepresentation (by misstatement or omission), based on statements it made in connection with the manufacture of a brand-name prescription drug, by a plaintiff claiming physical injury caused by a generic drug manufactured by a different company.”); Conte v. Wyeth, Inc., 168 Cal.App.4th 89 , 8 | 1 | 1 |
Chown v. USM Corp.green1 sentence1994See Chown v. USM Corp., 297 N.W.2d 218, 221-22 (Iowa 1980). | 1 | 1 |
Reed v. Chrysler Corp.green1 sentence1994On cross-appeal, plaintiff Hillriehs argues that: (1) the district court erred in setting aside the punitive damage award; and (2) in light of our decision in Reed v. Chrysler Corp., 494 N.W.2d 224, 230 (Iowa 1992), Hillrichs’s judgment should not be reduced by the fault attributed to him. | 1 | 1 |
| Case | Negative | Cited |
|---|---|---|
| No negative-treatment citations attached to this issue in Iowa. Read the followed side critically anyway. | ||
| Case | Cited | Years |
|---|---|---|
Wright v. Brooke Group Ltd.
green
2 sentences2009Therefore, Wright adopted a standard of risk-utility analysis, which incorporates a consideration of reasonableness, for design defect claims, 1 but chose to “label a claim based on a defective product design as a design defect claim without reference to strict liability or negligence.” Id. at 169 . 2009Therefore, Wright adopted a standard of risk-utility analysis, which incorporates a consideration of reasonableness, for design defect claims, 1 but chose to “label a claim based on a defective product design as a design defect claim without reference to strict liability or negligence.” Id. at 169 . | 4 | 2006–2009 |
Counted by distinct opinions that both name this issue and are annotated to the section; sections every opinion cites regardless of issue are not filtered here, so read the counts against the total above.
Opinions by the citing court's state. A doctrine retained in one state and abandoned in another shows up here as a year span that stalls.